Physician profile
Angela Cope
NPI 1154304731
$884.11
in general payments reported to CMS, 2019-2025
16 companies · $10.40 in 2025
The $10.40 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $115 · 2021: $99.58 · 2022: $117 · 2023: $110 · 2024: $217 · 2025: $10.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $188.86 | 2022-2025 | Nexplanon, Nuvaring |
| Abbvie INC. | $164.19 | 2019-2023 | Liletta, Orilissa, Lo Loestrin Fe |
| Pfizer INC. | $79.25 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $74.43 | 2019-2021 | |
| Astellas Pharma US INC | $55.77 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $53.25 | 2019-2023 | Myosure Tissue Removal Device |
| Avion Pharmaceuticals | $40.39 | 2019-2021 | |
| Allergan, INC. | $39.51 | 2019-2020 | |
| Ethicon US, LLC | $38.61 | 2019 | |
| Minerva Surgical, INC | $32.23 | 2024 | |
| Biogen, INC. | $27.50 | 2024 | Zurzuvae |
| Mayne Pharma Commercial LLC | $24.58 | 2023 | |
| Coopersurgical, INC. | $18.63 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.51 | 2022 | |
| Evofem Biosciences, INC. | $14.22 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $14.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Cope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.